WallStreetZenWallStreetZen

NYSE: ABT
Abbott Laboratories Stock

Overview
ForecastEarningsDividendOwnership
$125.35+4.91 (+4.08%)
Updated Jan 28, 2022
ABT Price
$125.35
Fair Value Price
N/A
Market Cap
$221.65B
52 Week Low
$105.36
52 Week High
$142.60
P/E
30.87x
P/B
6.4x
P/S
4.96x
PEG
2.55x
Dividend Yield
1.45%
Revenue
$42.31B
Earnings
$7.24B
Gross Margin
56.8%
Operating Margin
20.83%
Profit Margin
17.1%
Debt to Equity
1.13
Operating Cash Flow
$11B
Beta
0.87
Next Earnings
N/A
Ex-Dividend
Jan 13, 2022
Next Dividend
Feb 15, 2022

Zen Score

High
Medium
Low
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ABT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ABT ($125.35) is trading below its intrinsic value of $230.48, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
ABT is good value based on its earnings relative to its share price (30.87x), compared to the US market average 33.7x)
Valuation
ABT is poor value based... subscribe to Premium to read more.
Valuation
There are 34 more ABT due diligence checks available for Premium users.

ABT News

Valuation

ABT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
30.87x
Industry
27.08x
Market
33.7x
ABT is good value based... subscribe to Premium to read more.
Valuation
ABT is poor value based... subscribe to Premium to read more.
Valuation

ABT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.4x
Industry
4.36x
ABT is poor value based... subscribe to Premium to read more.
Valuation

ABT price to earnings growth (PEG)

For valuing profitable companies with growth potential
ABT is poor value relative... subscribe to Premium to read more.
Valuation

ABT's financial health

Profit margin

Revenue
$10.9B
Net Income
$2.1B
Profit Margin
19.2%
ABT's Earnings (EBIT) of $8.81B... subscribe to Premium to read more.
Financials
ABT's profit margin has increased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$73.8B
Liabilities
$39.2B
Debt to equity
1.13
ABT's short-term assets ($23.49B) exceed... subscribe to Premium to read more.
Financials
ABT's long-term liabilities ($26.29B) exceed... subscribe to Premium to read more.
Financials
ABT's debt has increased relative... subscribe to Premium to read more.
Financials
ABT's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$2.7B
Investing
-$651.0M
Financing
-$1.4B
ABT's operating cash flow ($11.26B)... subscribe to Premium to read more.
Financials

Abbott Laboratories Stock FAQ

What is Abbott Laboratories's quote symbol?

(NYSE: ABT) Abbott Laboratories trades on the NYSE under the ticker symbol ABT. Abbott Laboratories stock quotes can also be displayed as NYSE: ABT.

What is the 52 week high and low for Abbott Laboratories (NYSE: ABT)?

(NYSE: ABT) Abbott Laboratories's 52-week high was $142.60, and its 52-week low was $105.36. It is currently -12.1% from its 52-week high and 18.97% from its 52-week low.

How much is Abbott Laboratories stock worth today?

(NYSE: ABT) Abbott Laboratories currently has 1,768,286,969 outstanding shares. With Abbott Laboratories stock trading at $125.35 per share, the total value of Abbott Laboratories stock (market capitalization) is $221.65B.

Abbott Laboratories stock was originally listed at a price of $32.75 in Dec 31, 1997. If you had invested in Abbott Laboratories stock at $32.75, your return over the last 24 years would have been 282.75%, for an annualized return of 5.75% (not including any dividends or dividend reinvestments).

How much is Abbott Laboratories's stock price per share?

(NYSE: ABT) Abbott Laboratories stock price per share is $125.35 today (as of Jan 28, 2022).

What is Abbott Laboratories's Market Cap?

(NYSE: ABT) Abbott Laboratories's market cap is $221.65B, as of Jan 29, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abbott Laboratories's market cap is calculated by multiplying ABT's current stock price of $125.35 by ABT's total outstanding shares of 1,768,286,969.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.